Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.01 | 0.7 |
mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |